B4GALT7 Antikörper
Kurzübersicht für B4GALT7 Antikörper (ABIN7227446)
Target
Alle B4GALT7 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Verwendungszweck
- Rabbit Anti-B4GT7 Polyclonal Antibody
-
Spezifität
- The antibody detects endogenous levels of B4GT7 protein
-
Aufreinigung
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogen
- Synthesized peptide derived from part region of human B4GT7 protein
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-2000,ELISA 1:5000-20000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- PBS, 50 % glycerol, 0.05 % Proclin 300, 0.05 %BSA
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
-
Haltbarkeit
- 12 months
-
-
- B4GALT7 (Xylosylprotein beta 1,4-Galactosyltransferase, Polypeptide 7 (Galactosyltransferase I) (B4GALT7))
-
Andere Bezeichnung
- B4GT7
-
Hintergrund
- Beta-1,4-galactosyltransferase 7, Beta-1,4-GalTase 7, Beta4Gal-T7, b4Gal-T7, UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 7, UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 7, Xylosylprotein 4-beta-galactosyltransferase, Proteoglycan UDP-galactose:beta-xylose beta1,4-galactosyltransferase I, UDP-galactose:beta-xylose beta-1,4-galactosyltransferase, XGPT, XGalT-1, Xylosylprotein beta-1,4-galactosyltransferaseB4GALT7 (Beta-1,4-Galactosyltransferase 7) is a Protein Coding gene. Diseases associated with B4GALT7 include Ehlers-Danlos Syndrome With Short Stature And Limb Anomalies and Spondylodysplastic Ehlers-Danlos Syndrome. Among its related pathways are Glycosaminoglycan metabolism and Metabolism.
-
Molekulargewicht
- 35kD
-
Gen-ID
- 11285
-
UniProt
- Q9UBV7
-
Pathways
- Glycosaminoglycan Metabolic Process
Target
-